Free Trial
NASDAQ:NTUS

Natus Medical (NTUS) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$32.96
$32.96
50-Day Range
$32.96
$32.96
52-Week Range
$20.90
$33.93
Volume
1,514 shs
Average Volume
325,002 shs
Market Capitalization
$1.14 billion
P/E Ratio
89.08
Dividend Yield
N/A
Price Target
N/A
NTUS stock logo

About Natus Medical Stock (NASDAQ:NTUS)

Natus Medical Incorporated provides medical device solutions focuses on the diagnosis and treatment of patients with central nervous and sensory system disorders worldwide. It offers products and technologies used for the screening, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological and neurosurgical treatments, epilepsy, sleep disorders, and neuromuscular diseases. The company also provides computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology; and software systems for managing and tracking disorders and diseases for public health laboratories. In addition, it offers electroencephalography, long term monitoring, intensive care unit monitoring, electromyography, sleep analysis or polysomnography, and intra-operative monitoring solutions. Further, the company provides hearing assessment, screening, and instrument fitting solutions; jaundice management products; brain injury products; and eye imaging systems and products used in the advanced science and practice of neonatal and pediatric retinal imaging. Additionally, it offers essential products used in the everyday operation of neonatal intensive care unit (NICU); balance assessment systems to evaluate patients with balance disorders; and NICVIEW, a live streaming video for families with babies in the NICU. The company also provides computer-based audiological, otoneurologic, and vestibular instrumentation for hearing and balance care professionals. It serves university medical centers, public and private hospitals, physician offices, clinics, research laboratories, and others. The company was formerly known as ALGOTEK Instruments, Inc. and changed its name to Natus Medical Incorporated in September 1988. Natus Medical Incorporated was incorporated in 1987 and is headquartered in Middleton, Wisconsin.

NTUS Stock News Headlines

Natus Medical Incorporated
The #1 Crypto for 2024 (3 Cent Coin)
Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 different coins that have returned over 100%... Today, he is now making the biggest crypto call of his ENTIRE career…
This TSLA short trade is on a nine win hot streak
Most Tesla Shareholders are disappointed in the stock's performance in 2024. Year to date, it's down 30%... And things don’t seem to be getting better. That said, one professional trader has found a way to turn Tesla’s demise into a flurry of opportunity… In fact, he has not lost a single trade on Tesla this year. As of this mailing he’s 9 for 9 with incredible wins under his belt. Just see for yourself.
See More Headlines
Receive NTUS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Natus Medical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/04/2021
Today
7/27/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Electromedical Equipment
Sub-Industry
N/A
Current Symbol
NASDAQ:NTUS
Employees
1,400
Year Founded
N/A

Profitability

Net Income
$13.18 million
Pretax Margin
4.15%

Debt

Sales & Book Value

Annual Sales
$473.44 million
Cash Flow
$2.02 per share
Book Value
$12.44 per share

Miscellaneous

Free Float
34,166,000
Market Cap
$1.14 billion
Optionable
Optionable
Beta
0.22
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Key Executives

  • Mr. Thomas Joseph Sullivan (Age 58)
    Pres, CEO & Director
    Comp: $17.27k
  • Mr. Benjamin Drew Davies (Age 56)
    Exec. VP & CFO
    Comp: $812.16k
  • Mr. Austin F. Noll III (Age 55)
    Exec. VP & Chief Commercial Officer
    Comp: $756.19k
  • Mr. Seán Langan
    VP of Global Operations
  • Mr. Ivan Pandiyan
    VP of Global R&D
  • Mr. Douglas Balog
    VP, Gen. Counsel & Sec.
  • Ms. Lisa Paul (Age 58)
    Chief People Officer & VP

NTUS Stock Analysis - Frequently Asked Questions

How were Natus Medical's earnings last quarter?

Natus Medical Incorporated (NASDAQ:NTUS) released its earnings results on Thursday, November, 4th. The company reported $0.28 earnings per share for the quarter, missing the consensus estimate of $0.30 by $0.02. The business had revenue of $113.88 million for the quarter, compared to analysts' expectations of $116.60 million. Natus Medical had a net margin of 2.65% and a trailing twelve-month return on equity of 10.15%.

What other stocks do shareholders of Natus Medical own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Natus Medical investors own include AbbVie (ABBV), Algonquin Power & Utilities (AQN), BCE (BCE), Franklin Resources (BEN), Bank of Nova Scotia (BNS), British American Tobacco (BTI) and Carnival Co. & (CCL).

This page (NASDAQ:NTUS) was last updated on 7/27/2024 by MarketBeat.com Staff

From Our Partners